Sy Angela U, Hernandez Brenda Y, Tareg Aileen, Reichhardt Martina, Buenconsejo-Lum Lee
Pacific Cancer Projects, John A. Burns School of Medicine, University of Hawaii at Manoa, 677 Ala Moana Blvd #815, Honolulu, HI, 96813, United States.
Cancer Research Center of Hawaii, University of Hawaii, 701 Ilalo Street, Honolulu, HI, 96813, United States.
Cancer Epidemiol. 2017 Oct;50(Pt B):283-288. doi: 10.1016/j.canep.2017.07.008.
Non-invasive, self-collected sampling methods for HPV DNA detection in women, which are reliable, efficient, and acceptable have the potential to address barriers to cervical cancer screening in underserved communities, including low-middle income countries (LMIC) such as the island nation of the Federated States of Micronesia (FSM). Urine-based HPV testing has not been rigorously evaluated in clinical trials. A pilot community-based participatory randomized control research project evaluated use of urine HPV testing as a more culturally- and human resource appropriate method of cervical cancer screening in Yap State, FSM. Women participated in a cervical screening intervention using pap vs. urine test (N=217). This manuscript described attitudes about screening feasibility and preferences. Stakeholders and women participants were interviewed (N=23), and a survey also evaluated women's screening preferences (N=217). Qualitative content thematic analysis with multiple coders identified themes from interviews on acceptability and feasibility of screening tests. Women research participants were comfortable with the urine test (95%), despite limitations in some to provide samples. While 82.0% indicated that they felt comfortable with Pap smear, they also preferred a clinician (42%) to do the Pap smear, explaining that they preferred having a trained worker instead of themselves to do tests. Women want to be screened but accessibility remains a challenge. Education and training of professionals and community members alike will improve clinical skills, research capacity, knowledge of screening tests and behaviors including prioritizing HPV screening and testing.
用于女性人乳头瘤病毒(HPV)DNA检测的非侵入性、自我采集采样方法可靠、高效且可接受,有潜力消除包括低收入和中等收入国家(LMIC)如密克罗尼西亚联邦(FSM)这个岛国在内的服务欠缺社区宫颈癌筛查的障碍。基于尿液的HPV检测尚未在临床试验中得到严格评估。一个基于社区参与的试点随机对照研究项目评估了在FSM的雅浦州使用尿液HPV检测作为一种在文化和人力资源方面更合适的宫颈癌筛查方法。女性参与了一项使用巴氏涂片与尿液检测的宫颈筛查干预(N = 217)。本手稿描述了对筛查可行性和偏好的态度。对利益相关者和女性参与者进行了访谈(N = 23),并且一项调查还评估了女性的筛查偏好(N = 217)。由多名编码员进行的定性内容主题分析从关于筛查检测可接受性和可行性的访谈中确定了主题。女性研究参与者对尿液检测感到满意(95%),尽管有些人在提供样本方面存在困难。虽然82.0%的人表示对巴氏涂片感到满意,但她们也更希望由临床医生(42%)进行巴氏涂片,解释说她们更愿意让受过训练的工作人员而不是自己来进行检测。女性希望接受筛查,但可及性仍然是一个挑战。对专业人员和社区成员的教育与培训将提高临床技能、研究能力、对筛查检测的了解以及包括优先进行HPV筛查和检测在内的行为。